Jessica Stitt | Former VP, Finance and IR |
Rick Winningham | Chairman & CEO |
Brett Haumann | SVP, Clinical Development & Chief Medical Officer |
Frank Pasqualone | SVP & Chief Commercial Operations Officer |
Andrew Hindman | SVP & CFO |
Louise Chen | Cantor Fitzgerald & Co. |
Tyler Van Buren | Piper Jaffray Companies |
Geoffrey Porges | SVB Leerink |
Alan Carr | Needham & Company |
Ladies and gentlemen, good morning. At this time, I'd like to welcome everyone to the Theravance Biopharma Conference Call. [Operator Instructions]. Today's conference call is being recorded.
And now I would like to turn the call over to Jessica Stitt, Vice President Finance and Investor Relations.